1.48
2.68%
-0.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Tracon Pharmaceuticals Inc Borsa (TCON) Ultime notizie
Ocugen (NASDAQ:OCGN) versus TRACON Pharmaceuticals (NASDAQ:TCON) Critical Comparison - Defense World
Defense World
Tracon Pharmaceuticals announces executive departure By Investing.com - Investing.com Canada
Investing.com Canada
Tracon Pharmaceuticals announces executive departure By Investing.com - Investing.com
Investing.com
Tracon Pharmaceuticals announces executive departure - Investing.com India
Investing.com India
TRACON Pharmaceuticals, Inc. (TCON) To Go Ex-Dividend on June 27th - Defense World
Defense World
Can you still get a good price for TRACON Pharmaceuticals Inc (TCON) Shares at this point? – US Post News - US Post News
US Post News
TCON’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
The InvestChronicle
TCON’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
The InvestChronicle
Market Momentum: TRACON Pharmaceuticals Inc (TCON) Registers a -7.42 Decrease, Closing at 1.00 – DWinneX - The Dwinnex
The Dwinnex
TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded to Buy at StockNews.com - Defense World
Defense World
TRACON Pharmaceuticals Revs Up for Growth - All Finance Times
All Finance Times
TRACON Pharmaceuticals Revs Up for Growth - All Finance Times
All Finance Times
How will TRACON Pharmaceuticals Inc's (TCON) earnings compare to estimates this quarter? – US Post News - US Post News
US Post News
TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage ... - GlobeNewswire
GlobeNewswire
TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage ... - GlobeNewswire
GlobeNewswire
TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage ... - GlobeNewswire
GlobeNewswire
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Short Interest Down 18.9% in May - Defense World
Defense World
In the Green: TRACON Pharmaceuticals Inc (TCON) Closes at 1.25, Up/Down -17.22 from Previous Day – DWinneX - The Dwinnex
The Dwinnex
TRACON Pharmaceuticals (NASDAQ:TCON) Stock Price Passes Below 50 Day Moving Average of $3.55 - Defense World
Defense World
Tracon: 2Q Earnings Snapshot - Yahoo News UK
Yahoo News UK
TRACON Pharmaceuticals (NASDAQ:TCON) Rating Lowered to Hold at StockNews.com - Defense World
Defense World
TRACON Pharmaceuticals (NASDAQ:TCON) Rating Lowered to Hold at StockNews.com - Defense World
Defense World
David Lazar Joins TRACON Pharmaceuticals as Chief Business Officer - TipRanks.com - TipRanks
TipRanks
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
GlobeNewswire
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance
Yahoo Finance
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance
Yahoo Finance
David Lazar Joins TRACON Pharmaceuticals as Chief Business Officer - TipRanks.com - TipRanks
TipRanks
TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Lowered by StockNews.com - Defense World
Defense World
TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Lowered by StockNews.com - Defense World
Defense World
TRACON Pharmaceuticals (TCON) to Release Earnings on Tuesday - Defense World
Defense World
Shareholders Should Check The Ownership Structure Of TRACON Pharmaceuticals Inc (NASDAQ:TCON) - Yahoo Movies Canada
Yahoo Movies Canada
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 - Yahoo Canada Finance
Yahoo Canada Finance
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 - Yahoo Finance
Yahoo Finance
TRACON Pharmaceuticals (NASDAQ:TCON) Stock Price Crosses Below Two Hundred Day Moving Average of $4.04 - Defense World
Defense World
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day ... - Markets Insider
Markets Insider
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Markets Insider
Markets Insider
UTHR: 3 Promising Biotech Stocks Driving Weekly Gains - StockNews.com
StockNews.com
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024 - InvestorPlace
InvestorPlace
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024 - InvestorPlace
InvestorPlace
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
TRACON Pharmaceuticals Announces Reverse Stock Split
GlobeNewswire Inc.
Shares of Tracon Pharmaceuticals Tumble 22% on Reverse Split - MarketWatch
MarketWatch
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent ... - Yahoo Finance
Yahoo Finance
Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Benzinga
Capitalizzazione:
|
Volume (24 ore):